BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/15/2026 6:29:16 AM | Browse: 97 | Download: 145
 |
Received |
|
2025-07-23 02:30 |
|
Peer-Review Started |
|
2025-07-23 02:30 |
|
First Decision by Editorial Office Director |
|
2025-08-01 09:33 |
|
Return for Revision |
|
2025-08-01 09:33 |
|
Revised |
|
2025-08-13 16:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-02 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-02 22:34 |
|
Articles in Press |
|
2026-02-02 22:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-27 07:07 |
|
Publish the Manuscript Online |
|
2026-03-15 06:19 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maha Bouziane, Omar Moufid and Rachida Habbal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maha Bouziane, Assistant Professor, cardiology department, Ibn Rochd university Hospital of Casablanca, Corresponding author. Tel: 00212522482020/(P.269), Email: <email>mahabouziane@gmail.com</email>, Casablanca 20000, Casablanca-Settat, Morocco. mahabouziane@gmail.com |
| Key Words |
Cardiac amyloidosis; Light chains; Transthyretin; Diagnosis; Treatment |
| Core Tip |
This review highlights recent advances in cardiac amyloidosis (CA), a progressive infiltrative cardiomyopathy caused by amyloid fibril deposition in cardiac tissues. Improved recognition through advanced non-invasive imaging techniques and significant progress in disease-modifying therapies have transformed diagnosis and treatment. A multimodal diagnostic strategy and early identification are critical to improving patient outcomes. The review emphasizes the need for standardized diagnostic algorithms, increased clinical awareness, and a multidisciplinary approach to optimize care for patients with CA. |
| Publish Date |
2026-03-15 06:19 |
| Citation |
Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270 |
| URL |
https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v16.i1.112270 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
